Note: The Trevi Fountain is closed until September 2025 due to maintenance. A temporary pool has been set up for visitors to throw coins into. A must-see on many travelers' itineraries ...
Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report) on January 10 and set a price target of $7.00. Discover outperforming stocks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback